Search clinical trials for: Primary & booster vaccination

Total 19411 results

WestVac Biopharma Co., Ltd.

Not yet recruiting

A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination

COVID-19
University of Zurich
Merck Sharp & Dohme LLC

Recruiting

Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination (MIPS)

Measles | Rubella | Mumps

Switzerland
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)

Recruiting

Impact of Standing Orders Optimization

Human Papilloma Virus

United States
Binhui Biopharmaceutical Co., Ltd.

Recruiting

Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years

COVID-19

China
University of California, Los Angeles

Recruiting

Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up

COVID-19 | Vaccines

United States
ANRS, Emerging Infectious Diseases
Saint-Louis Hospital, Paris, France; Hôpital Cochin; Bichat Hospital

Not yet recruiting

Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination

HIV Infections | Yellow Fever
Kirby Institute
Medical Research Future Fund; Seqirus Pty Ltd, Australia

Recruiting

Immunosuppression and COVID-19 Boosters

COVID-19

Australia
Pfizer
National Heart, Lung, and Blood Institute (NHLBI); Carelon Research

Recruiting

A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

Myocarditis

United States, Canada
Federal University of Espirito Santo
Centro de Pesquisas René Rachou; Secretaria de Estado da Saúde do Espírito...

Not yet recruiting

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly (Plus_Booster)

COVID-19 | Vaccine Adverse Reaction | Vaccine-Preventable Diseases

Brazil
Seoul National University Hospital

Recruiting

Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients (CoVaKT)

Renal Transplant | COVID-19 Vaccination

Korea, Republic of
University Medical Center Groningen
PRA Health Sciences; TRACER Europe BV

Recruiting

Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study) (ACT-BOOSTER)

COVID-19

Netherlands
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan; Academia Sinica, Taiwan

Recruiting

The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort (IRHBRVD)

Hepatitis B | Vaccination; Infection | Preventable Disease, Vaccine

Taiwan
Erasmus Medical Center
University Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaborators

Recruiting

A Trial Among HealthCare Workers (HCW) Vaccinated With Janssen Vaccine: the SWITCH Trial (SWITCH)

Covid19

Netherlands
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma

China
Université de Reims Champagne-Ardenne

Recruiting

Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization (Info-Vac)

Vaccination

France
The University of Texas Health Science Center at...
Massachusetts General Hospital; 59th Medical Wing; Uniformed Services University... and other collaborators

Recruiting

Chronic Pain Management In Primary Care Using Behavioral Health Consultants

Chronic Pain

United States
Region Örebro County

Not yet recruiting

Primary TBE Vaccination for the Elderly

Vaccine | Tick-borne Encephalitis

Sweden
Queen Saovabha Memorial Institute

Recruiting

Immunological Tolerance After Frequent Rabies Booster Vaccinations

Rabies

Thailand
Queen Saovabha Memorial Institute

Recruiting

Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults

Rabies

Thailand
Queen Saovabha Memorial Institute
Chulalongkorn University

Recruiting

Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults

Rabies

Thailand
Sanford Health
National Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaborators

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)

Mitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditions

United States, Australia
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI); Massachusetts General Hospital; Dana-Farber... and other collaborators

Active, not recruiting

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
Duke University
Washington University School of Medicine; University of Pittsburgh; Centers for... and other collaborators

Completed

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

COVID-19 | Influenza

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4)

Pneumococcal Disease

United States, Austria, Canada, Denmark, Finland, Israel, Poland, Spain
Hipra Scientific, S.L.U

Active, not recruiting

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

SARS-CoV2 Infection

Spain
Seqirus
Biomedical Advanced Research and Development Authority

Active, not recruiting

Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

Infections | Virus Diseases | Respiratory Tract Infections | Influenza, Human | Infection Viral

United States
Sanofi Pasteur, a Sanofi Company
GlaxoSmithKline

Completed

Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older (VAT00002)

COVID-19

Honduras, United States, Australia, France, New Zealand, Spain, United Kingdom
Washington University School of Medicine
National Cancer Institute (NCI)

Completed

Increasing Optimal Use of HPV Vaccination in Primary Care

Human Papillomavirus Vaccines

United States
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI); University of Wisconsin, Madison

Enrolling by invitation

Engaging Clinical Champions to Improve HPV Vaccination

Human Papilloma Virus

United States
University Hospital, Montpellier

Active, not recruiting

Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician

Chronic Heart Failure

France
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.; Autoimmunity Centers of Excellence

Completed

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Systemic Lupus Erythematosus (SLE) | Multiple Sclerosis (MS) | Rheumatoid Arthritis (RA) | Juvenile Dermatomyositis (JDM) | Juvenile Idiopathic Arthritis (JIA) | Pemphigus Vulgaris | Systemic Sclerosis (SSc) | Pediatric SLE | Pediatric-Onset Multiple Sclerosis (POMS)

United States
Murdoch Childrens Research Institute
Indonesia University; Universitas Padjadjaran; Health Development Policy Agency... and other collaborators

Withdrawn

Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)

COVID-19

Indonesia
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine (CoVFlu)

COVID-19 | Influenza

Italy
Fundacio d'Investigacio en Atencio Primaria Jordi...

Completed

Use of Virtual Reality in the Reduction of Pain After the Administration of Vaccines Among Children in Primary Care Centers.

Pain | Virtual Reality | Pediatrics | Vaccination

Spain
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

COVID-19 | SARS-CoV-2

Australia, United States, Philippines
Health Institutes of Turkey

Completed

Phase 3 Booster Vaccination Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Hipra Scientific, S.L.U
Laboratorios Hipra, S.A.

Completed

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
University Hospital Southampton NHS Foundation...

Completed

Immune Responses to COVID-19 Vaccination in Lymphoma Patients (PROSECO)

Follicular Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Classical Hodgkin Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Nodular Lymphocyte... and other conditions

United Kingdom
Novavax

Active, not recruiting

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years (COVID-19)

COVID-19

Spain, United States, South Africa, Mexico, United Kingdom, Philippines, Colombia, Dominican Republic, Guatemala, Honduras
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

Meningococcal Infection (Healthy Volunteers)

Puerto Rico, United States
London School of Hygiene and Tropical Medicine
University of Sierra Leone; Innovative Medicines Initiative

Completed

Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study)

Ebola Virus Disease

Sierra Leone
The University of Hong Kong

Active, not recruiting

Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)

COVID-19 Vaccination

Hong Kong
University Children's Hospital Tuebingen
German Cancer Research Center; University Hospital Tuebingen; Universität Tübingen

Completed

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults

Germany
Health Institutes of Turkey

Completed

Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Health Institutes of Turkey

Completed

Booster Vaccination Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Takeda

Completed

A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Coronavirus Disease (COVID-19)

Japan
Oliver Cornely, MD
European Commission; VACCELERATE

Completed

Assessing Immune Response of Different COVID-19 Vaccines in Older Adults (EU-COVAT-1)

COVID-19 | Vaccination; Infection | Vaccination Reaction

Spain, Ireland, Germany, Norway, Lithuania
Federal University of Mato Grosso
Stanford University; Oswaldo Cruz Foundation

Withdrawn

BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population (PPT-BCG)

Latent Tuberculosis

Brazil
Mayo Clinic
National Cancer Institute (NCI)

Completed

Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination

Papillomavirus Vaccines

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China

Search clinical trials for: Primary & booster vaccination

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations